TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose TRIM29 overexpression has been reported in several human malignancies and showed correlation with cancer cell malignancy. The aim of the current study is to examine its clinical significance and biological roles in human bladder cancer tissues and cell lines. Materials and Methods A total of 102 cases of bladder cancer tissues were examined for TRIM29 expression by immunohistochemistry. siRNA and plasmid transfection were performed in 5637 and BIU- 87 cell lines. Cell Counting Kit-8, flow cytometry, western blot, and real-time polymerase chain reaction were performed to examine its biological roles and mechanism in bladder cancer cells. Results We found that TRIM29 overexpression showed correlation with invading depth (p=0.0087). Knockdown of TRIM29 expression in bladder cancer cell line 5637 inhibited cell growth rate and cell cycle transition while its overexpression in BIU-87 cells accelerated cell proliferation and cell cycle progression. TRIM29 overexpression also inhibited cell apoptosis induced by cisplatin. In addition, we demonstrated that TRIM29 depletion decreased while its overexpression led to upregulated expression of cyclin D1, cyclin E, and Bcl-2. We also showed that TRIM29 knockdown inhibited protein kinase C (PKC) and nuclear factor B (NF-B) signaling while its overexpression stimulated the PKC and NF-B pathways. BAY 11-7082 (NF-B inhibitor) partly attenuated the effect of TRIM29 on expression of cyclin and Bcl-2. Treatment with PKC inhibitor staurosporine resulted in ameliorated TRIM29 induced activation of NF-B. Conclusion The current study demonstrated that TRIM29 upregulates cyclin and Bcl family proteins level to facilitate malignant cell growth and inhibit drug-induced apoptosis in bladder cancer, possibly through PKC–NF-B signaling pathways.
Abstract
Purpose TRIM29 overexpression has been reported in several human malignancies and showed correlation with cancer cell malignancy. The aim of the current study is to examine its clinical significance and biological roles in human bladder cancer tissues and cell lines. Materials and Methods A total of 102 cases of bladder cancer tissues were examined for TRIM29 expression by immunohistochemistry. siRNA and plasmid transfection were performed in 5637 and BIU- 87 cell lines. Cell Counting Kit-8, flow cytometry, western blot, and real-time polymerase chain reaction were performed to examine its biological roles and mechanism in bladder cancer cells. Results We found that TRIM29 overexpression showed correlation with invading depth (p=0.0087). Knockdown of TRIM29 expression in bladder cancer cell line 5637 inhibited cell growth rate and cell cycle transition while its overexpression in BIU-87 cells accelerated cell proliferation and cell cycle progression. TRIM29 overexpression also inhibited cell apoptosis induced by cisplatin. In addition, we demonstrated that TRIM29 depletion decreased while its overexpression led to upregulated expression of cyclin D1, cyclin E, and Bcl-2. We also showed that TRIM29 knockdown inhibited protein kinase C (PKC) and nuclear factor B (NF-B) signaling while its overexpression stimulated the PKC and NF-B pathways. BAY 11-7082 (NF-B inhibitor) partly attenuated the effect of TRIM29 on expression of cyclin and Bcl-2. Treatment with PKC inhibitor staurosporine resulted in ameliorated TRIM29 induced activation of NF-B. Conclusion The current study demonstrated that TRIM29 upregulates cyclin and Bcl family proteins level to facilitate malignant cell growth and inhibit drug-induced apoptosis in bladder cancer, possibly through PKC–NF-B signaling pathways.
참고문헌 (19)
- Siegel R, "Cancer statistics, 2012", CA Cancer J Clin, 62, pp.10~29 (2012)
- Kosaka Y, "Tripartite motif-containing 29(TRIM29)is a novel marker for lymph node metastasis in gastric cancer", Ann Surg Oncol, 14, pp.2543~2549 (2007)
- Li Q, "Tripartite motif 8(TRIM8)modulates TNFalpha-and IL-1beta-triggered NF-kappaB activation by targeting TAK1 for K63-linked polyubiquitination", Proc Natl Acad Sci U S A, 108, pp.19341~19346 (2011)
- Noguchi K, "TRIM40 promotes neddylation of IKKgamma and is downregulated in gastrointestinal cancers", Carcinogenesis, 32, pp.995~1004 (2011)
- Tang ZP, "Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-kappaB pathway", PLoS One, 8, pp.63676~ (2013)
- Kanno Y, "TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer", Acta Histochem, 116, pp.708~712 (2014)
- Liu J, "TRIM29functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer", Am J Pathol, 180, pp.839~847 (2012)
- Jiang T, "Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer", Med Oncol, 30, pp.715~ (2013)
- Seo M, "Inhibitory heterotrimeric GTP-binding proteins inhibit hydrogen peroxide-induced apoptosis by up-regulation of Bcl-2 via NF-kappaB in H1299human lung cancer cells", Biochem Biophys Res Commun, 381, pp.153~158 (2009)
- Knudsen KE, "Cyclin D1 : polymorphism, aberrant splicing and cancer risk", Oncogene, 25, pp.1620~1628 (2006)
- Juan G, "Intranuclear compartmentalization of cyclin E during the cell cycle : disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer", Cancer Res, 61, pp.1220~1226 (2001)
- Cho HJ, "Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells", Cancer Lett, 237, pp.56~66 (2006)
- Schaaf A, "Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides", Urol Oncol, 22, pp.188~192 (2004)
- Lee SJ, "Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-kappaB-mediated MMP-9 expression inducing the MAPK pathway", Cell Signal, 24, pp.1734~1742 (2012)
- Kim JK, "Up-regulation of Bfl-1", A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line, 2004, pp.212, 61~70
- Miao Z, "CARMA3is overexpressed in colon cancer and regulates NF-kappaB activity and cyclin D1 expression", Biochem Biophys Res Commun, 425, pp.781~787 (2012)
- El-Kady A, "Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-kappaB and Bcl-2 families", J Carcinog, 10, pp.24~ (2011)
- Wang X, "Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC", RAF, NF-kappaB-dependent pathway, pp.Oncogene, 2004[DOI]
- Shi MD, "Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 breast adenocarcinoma cells invasion", migration by alpha-tomatine through activating PKCalpha, NF-kappaB-dependent MMP-2, pp.MMP-9 expressions, Cell Biochem Biophys[DOI]